17.02.2005 21:17:00

Frost & Sullivan Recognizes Dade Behring Asia Pacific/Japan as Leader

Frost & Sullivan Recognizes Dade Behring Asia Pacific/Japan as Leader in Business Development Strategy


    Business Editors

    DEERFIELD, Ill.--(BUSINESS WIRE)--Feb. 17, 2005--

    Leading Industry Analysis and Award Honors Dade Behring APAC for
    Excellence in Business Development, Superior Market Growth Skills,
    Best Perception of Customer Needs

    Dade Behring (NASDAQ:DADE), the world's largest company solely dedicated to clinical diagnostics, today announced that it has been recognized by Frost & Sullivan with the 2004 Business Development Strategy Award for the IVD marketplace in Asia and Japan. Based on predetermined analysis of new segments, the number of new customers and commitment to business expansion, Dade Behring has been ranked number one in the industry.
    "Dade Behring has done an exceptional job in the Japanese, Chinese and Indian markets in achieving a very high level of customer satisfaction through their customer-centered product development," said Mr. Raghavendra Chitta, Research Analyst, Frost & Sullivan. "Innovation and sound business management are the cornerstones of their strategy and their success in Asia Pacific and Japan, making this company an ideal recipient of our strategy award for leadership."
    The Frost & Sullivan Award for Business Development Strategy is presented each year to the company that has demonstrated the highest level of excellence in business development within its industry. The award recognizes the company's ability to best perceive consumer needs, develop products and/or services that meet user needs, successfully introduce products or services to the industry, and identify new market segments to expand the existing customer base.
    "Through dedication and a passionate commitment to addressing our customers' real needs, Dade Behring works to provide broad-based solutions to the challenges our customers face on a day-to-day basis," said Jean-Luc Devleeschauwer, Regional Vice President Asia Pacific/Japan, Dade Behring. "This award confirms that our high standards have built trust and loyalty among our customers and have made us 'people you can count on, with solutions you need.'"
    The award was presented at Frost & Sullivan's Excellence in Healthcare awards banquet on February 15, 2005 at the Novotel Hotel in London, and has been published in the Growth and Opportunity newsletter, "Pharmaceuticals and Biotechnology," sent to the Frost & Sullivan industry-specific data base. The awards banquet was preceded by a CEO roundtable on "Global Excellence in Medical Technologies," where Dade Behring was represented by Donal Quinn, President, Global Customer Management. The event marked Frost & Sullivan's first European Excellence in Healthcare awards presentation.

    About Frost & Sullivan

    Founded in 1961, Frost & Sullivan is recognized as a global leader in growth consulting. Frost & Sullivan Awards are presented to companies that demonstrate excellence in their industry, commending the diligence, commitment, and innovative business strategies required to advance in the global marketplace. Frost & Sullivan rigorously analyzes specific criteria to determine award recipients in a vast variety of market industries and landscapes. For further information, visit www.frost.com.

    About Dade Behring

    With 2003 revenues of over $1.4 billion, Dade Behring is the world's largest company dedicated solely to clinical diagnostics. It offers a wide range of products, systems and services designed to meet the day-to-day needs of labs, delivering innovative solutions to customers and enhancing the quality of life for patients. Additional company information is available on the internet at www.dadebehring.com.

--30--CE/cg*

CONTACT: Dade Behring Pattie Overstreet-Miller, 847-267-5426 Connie DuBois, 847-267-3171

KEYWORD: ILLINOIS JAPAN INTERNATIONAL ASIA PACIFIC INDUSTRY KEYWORD: BANKING MEDICAL DEVICES PRODUCT SOURCE: Dade Behring

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Dade Behring Holdings Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Dade Behring Holdings Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 627,44 -0,28%